JP2012501986A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012501986A5 JP2012501986A5 JP2011525465A JP2011525465A JP2012501986A5 JP 2012501986 A5 JP2012501986 A5 JP 2012501986A5 JP 2011525465 A JP2011525465 A JP 2011525465A JP 2011525465 A JP2011525465 A JP 2011525465A JP 2012501986 A5 JP2012501986 A5 JP 2012501986A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- medicament
- preparation
- treatment
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 2
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 208000009935 visceral pain Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08015625 | 2008-09-05 | ||
| EP08015625.0 | 2008-09-05 | ||
| PCT/EP2009/006424 WO2010025931A2 (en) | 2008-09-05 | 2009-09-04 | Pharmaceutical combination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014251851A Division JP2015096530A (ja) | 2008-09-05 | 2014-12-12 | 医薬配合剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012501986A JP2012501986A (ja) | 2012-01-26 |
| JP2012501986A5 true JP2012501986A5 (enExample) | 2014-07-24 |
| JP5731387B2 JP5731387B2 (ja) | 2015-06-10 |
Family
ID=40345058
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525465A Active JP5731387B2 (ja) | 2008-09-05 | 2009-09-04 | 医薬配合剤 |
| JP2014251851A Pending JP2015096530A (ja) | 2008-09-05 | 2014-12-12 | 医薬配合剤 |
| JP2016240032A Pending JP2017071636A (ja) | 2008-09-05 | 2016-12-12 | 医薬配合剤 |
| JP2019070282A Pending JP2019131578A (ja) | 2008-09-05 | 2019-04-02 | 医薬配合剤 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014251851A Pending JP2015096530A (ja) | 2008-09-05 | 2014-12-12 | 医薬配合剤 |
| JP2016240032A Pending JP2017071636A (ja) | 2008-09-05 | 2016-12-12 | 医薬配合剤 |
| JP2019070282A Pending JP2019131578A (ja) | 2008-09-05 | 2019-04-02 | 医薬配合剤 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20100063148A1 (enExample) |
| EP (2) | EP2331210B1 (enExample) |
| JP (4) | JP5731387B2 (enExample) |
| KR (3) | KR101730924B1 (enExample) |
| CN (2) | CN105520924B (enExample) |
| AR (2) | AR073361A1 (enExample) |
| AU (3) | AU2009289776A1 (enExample) |
| BR (1) | BRPI0920521A2 (enExample) |
| CA (1) | CA2735857C (enExample) |
| CL (1) | CL2011000317A1 (enExample) |
| CO (1) | CO6382142A2 (enExample) |
| CY (2) | CY1115751T1 (enExample) |
| DK (2) | DK2331210T3 (enExample) |
| EC (1) | ECSP11010869A (enExample) |
| ES (2) | ES2719900T3 (enExample) |
| HR (2) | HRP20140663T1 (enExample) |
| HU (1) | HUE043278T2 (enExample) |
| IL (3) | IL211135A (enExample) |
| LT (1) | LT2735338T (enExample) |
| MX (1) | MX2011002339A (enExample) |
| PE (5) | PE20142357A1 (enExample) |
| PL (2) | PL2735338T3 (enExample) |
| PT (2) | PT2331210E (enExample) |
| RU (2) | RU2571501C2 (enExample) |
| SI (2) | SI2735338T1 (enExample) |
| TR (1) | TR201904388T4 (enExample) |
| WO (1) | WO2010025931A2 (enExample) |
| ZA (1) | ZA201101449B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
| TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
| ES2531118T5 (es) | 2006-06-15 | 2022-06-14 | Ucb Pharma Gmbh | Composición farmacéutica que comprende lacosamida y levetiracetamo para uso en el tratamiento de la epilepsia |
| HUE043278T2 (hu) * | 2008-09-05 | 2019-08-28 | Gruenenthal Gmbh | 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolt és pregabalint vagy gabapentint tartalmazó gyógyszerkombináció |
| US20100190752A1 (en) | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
| FR2943246B1 (fr) * | 2009-03-19 | 2011-07-29 | Biocodex | Compose pour son utilisation dans le traitement des neuropathies peripheriques |
| JP6133772B2 (ja) | 2010-06-15 | 2017-05-24 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 痛み治療用の医薬配合物 |
| WO2012003968A1 (en) | 2010-07-06 | 2012-01-12 | Grünenthal GmbH | Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
| WO2012015027A1 (ja) | 2010-07-30 | 2012-02-02 | 東レ株式会社 | 神経障害性疼痛の治療剤又は予防剤 |
| EA024193B1 (ru) * | 2011-03-04 | 2016-08-31 | Грюненталь Гмбх | Фармацевтическая композиция на водной основе, предназначенная для парентерального введения тапентадола |
| US11413239B2 (en) * | 2011-07-20 | 2022-08-16 | Torrent Pharmaceuticals Ltd. | Pharmaceutical composition of tapentadol for nasal administration |
| BR112014000969A2 (pt) * | 2011-07-29 | 2017-04-18 | Gruenenthal Gmbh | administração intratecal ou epidural de 3-[(1s,2s)-3-(dimetilamino)- 1-etil-2-metilpropil]fenol |
| US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
| US9855286B2 (en) * | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
| US9320725B2 (en) * | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
| US20130310435A1 (en) * | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
| US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
| US8912226B2 (en) * | 2012-05-18 | 2014-12-16 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
| US9345689B2 (en) * | 2012-05-18 | 2016-05-24 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant |
| US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
| JP6360488B2 (ja) * | 2012-11-01 | 2018-07-18 | トレント・ファーマシューティカルズ・リミテッドＴｏｒｒｅｎｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ | 非経口投与のためのタペンタドールの薬学的組成物 |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| CN103655523A (zh) * | 2013-12-24 | 2014-03-26 | 南京艾德凯腾生物医药有限责任公司 | 他喷他多组合物 |
| HUE053114T2 (hu) | 2015-12-22 | 2021-06-28 | Zogenix International Ltd | Fenfluramin kompozíciók és eljárások azok elõállítására |
| WO2017112701A1 (en) | 2015-12-22 | 2017-06-29 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
| WO2018037306A1 (en) | 2016-08-24 | 2018-03-01 | Zogenix International Limited | Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| KR20190081385A (ko) | 2017-12-29 | 2019-07-09 | 강원대학교산학협력단 | 옥스카바제핀을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| CA3097335A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| SG11202104378SA (en) | 2018-11-19 | 2021-05-28 | Zogenix International Ltd | Methods of treating rett syndrome using fenfluramine |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US5330761A (en) | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
| US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5399362A (en) | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6562865B1 (en) * | 1999-08-20 | 2003-05-13 | Ortho-Mcneil Pharmaceutical, Inc. | Composition comprising a tramadol material and an anticonvulsant drug |
| US20060167032A1 (en) * | 2002-01-16 | 2006-07-27 | Galer Bradley S | Pharmaceutical composition and method for treating disorders of the central nervous system |
| IL162932A0 (en) * | 2002-02-22 | 2005-11-20 | Warner Lambert Co | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 |
| WO2007005716A2 (en) * | 2005-06-30 | 2007-01-11 | Cinergen, Llc | Methods of treatment and compositions for use thereof |
| US20090082466A1 (en) * | 2006-01-27 | 2009-03-26 | Najib Babul | Abuse Resistant and Extended Release Formulations and Method of Use Thereof |
| PL2012763T3 (pl) * | 2006-04-28 | 2011-08-31 | Gruenenthal Gmbh | Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylo-propylo)-fenol i NSAID |
| WO2008027442A2 (en) * | 2006-08-30 | 2008-03-06 | Theraquest Biosciences, Llc | Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
| CN102065852B (zh) * | 2007-11-23 | 2015-06-17 | 格吕伦塔尔有限公司 | 他喷他多组合物 |
| JP5563483B2 (ja) * | 2008-01-25 | 2014-07-30 | ゼノポート，インコーポレイティド | アシロキシアルキルカルバメートプロドラッグの合成に使用されるアシロキシアルキルチオカーボネートの鏡像異性的な分解 |
| HUE043278T2 (hu) * | 2008-09-05 | 2019-08-28 | Gruenenthal Gmbh | 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolt és pregabalint vagy gabapentint tartalmazó gyógyszerkombináció |
-
2009
- 2009-09-04 HU HUE14000597A patent/HUE043278T2/hu unknown
- 2009-09-04 PE PE2014001115A patent/PE20142357A1/es active IP Right Grant
- 2009-09-04 AR ARP090103405A patent/AR073361A1/es not_active Application Discontinuation
- 2009-09-04 EP EP09778335.1A patent/EP2331210B1/en active Active
- 2009-09-04 PT PT97783351T patent/PT2331210E/pt unknown
- 2009-09-04 SI SI200931945T patent/SI2735338T1/sl unknown
- 2009-09-04 ES ES14000597T patent/ES2719900T3/es active Active
- 2009-09-04 KR KR1020167018592A patent/KR101730924B1/ko not_active Expired - Fee Related
- 2009-09-04 MX MX2011002339A patent/MX2011002339A/es active IP Right Grant
- 2009-09-04 DK DK09778335.1T patent/DK2331210T3/da active
- 2009-09-04 PE PE2011000206A patent/PE20110291A1/es active IP Right Grant
- 2009-09-04 PL PL14000597T patent/PL2735338T3/pl unknown
- 2009-09-04 CN CN201510736012.5A patent/CN105520924B/zh not_active Expired - Fee Related
- 2009-09-04 KR KR1020177010825A patent/KR101851120B1/ko not_active Expired - Fee Related
- 2009-09-04 ES ES09778335.1T patent/ES2513394T3/es active Active
- 2009-09-04 PE PE2014001117A patent/PE20142372A1/es active IP Right Grant
- 2009-09-04 RU RU2011112444/15A patent/RU2571501C2/ru active
- 2009-09-04 DK DK14000597.6T patent/DK2735338T3/en active
- 2009-09-04 US US12/554,235 patent/US20100063148A1/en not_active Abandoned
- 2009-09-04 AU AU2009289776A patent/AU2009289776A1/en not_active Abandoned
- 2009-09-04 PE PE2018003303A patent/PE20190914A1/es unknown
- 2009-09-04 WO PCT/EP2009/006424 patent/WO2010025931A2/en not_active Ceased
- 2009-09-04 HR HRP20140663AT patent/HRP20140663T1/hr unknown
- 2009-09-04 BR BRPI0920521A patent/BRPI0920521A2/pt not_active Application Discontinuation
- 2009-09-04 EP EP14000597.6A patent/EP2735338B1/en not_active Not-in-force
- 2009-09-04 RU RU2014138166A patent/RU2674150C1/ru active
- 2009-09-04 KR KR1020117005044A patent/KR101641519B1/ko not_active Expired - Fee Related
- 2009-09-04 JP JP2011525465A patent/JP5731387B2/ja active Active
- 2009-09-04 SI SI200931014T patent/SI2331210T1/sl unknown
- 2009-09-04 CN CN200980135117.8A patent/CN102159284B/zh not_active Expired - Fee Related
- 2009-09-04 PE PE2014001116A patent/PE20142371A1/es active IP Right Grant
- 2009-09-04 CA CA2735857A patent/CA2735857C/en not_active Expired - Fee Related
- 2009-09-04 PT PT14000597T patent/PT2735338T/pt unknown
- 2009-09-04 LT LTEP14000597.6T patent/LT2735338T/lt unknown
- 2009-09-04 PL PL09778335T patent/PL2331210T3/pl unknown
- 2009-09-04 TR TR2019/04388T patent/TR201904388T4/tr unknown
-
2011
- 2011-02-09 IL IL211135A patent/IL211135A/en active IP Right Grant
- 2011-02-14 CL CL2011000317A patent/CL2011000317A1/es unknown
- 2011-02-16 CO CO11018461A patent/CO6382142A2/es active IP Right Grant
- 2011-02-23 ZA ZA2011/01449A patent/ZA201101449B/en unknown
- 2011-03-04 EC EC2011010869A patent/ECSP11010869A/es unknown
-
2014
- 2014-09-16 CY CY20141100748T patent/CY1115751T1/el unknown
- 2014-12-12 JP JP2014251851A patent/JP2015096530A/ja active Pending
-
2015
- 2015-02-24 IL IL237392A patent/IL237392B/en active IP Right Grant
- 2015-02-24 IL IL237391A patent/IL237391A/en active IP Right Grant
-
2016
- 2016-05-11 AU AU2016203053A patent/AU2016203053B2/en not_active Ceased
- 2016-12-12 JP JP2016240032A patent/JP2017071636A/ja active Pending
-
2018
- 2018-04-26 AU AU2018202879A patent/AU2018202879B2/en not_active Ceased
-
2019
- 2019-03-13 HR HRP20190500TT patent/HRP20190500T1/hr unknown
- 2019-03-27 CY CY20191100357T patent/CY1121492T1/el unknown
- 2019-04-02 JP JP2019070282A patent/JP2019131578A/ja active Pending
- 2019-07-19 AR ARP190102034A patent/AR117613A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501986A5 (enExample) | ||
| MX2010003299A (es) | Oligonucleotidos muy cortos (micromirs). | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
| JP2014530840A5 (enExample) | ||
| SMT201600273B (it) | Genz 112638 per trattare la malattia di gaucher o fabry in terapia di combinazione | |
| IL216599A (en) | 4,1-Bi-Conjugated Phthalazine History, Pharmaceuticals Containing Them and Their Use in Cancer Treatment | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| JP2013514381A5 (enExample) | ||
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| IL219610A (en) | Preparations containing a history of 3-hydroxy-2-oxo-1,2-dihydropyridine for use in the treatment or preparation of a drug for the treatment of epithelial tissue inflammation | |
| CY1114960T1 (el) | Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου | |
| JP2011528248A5 (enExample) | ||
| JP2010525055A5 (enExample) | ||
| CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
| JP2014054318A5 (enExample) | ||
| JP2009532412A5 (enExample) | ||
| WO2015004634A3 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| Fields | The psychology of pain | |
| JP2009126813A5 (enExample) | ||
| TH92434B (th) | เก้าอี้ | |
| UA102529C2 (en) | Microribonucleic acids | |
| TH102233B (th) | เตียงนอนแบบปรับระดับพนักพิง | |
| JP2007151536A5 (enExample) | ||
| TH93116B (th) | เก้าอี้ |